08045478006
info@ygiispharma.com
alectinib capsule

alectinib capsule

5.2 USD ($)/Bottle

Product Details:

  • Salt Composition Alectinib Hydrochloride
  • Indication Non-small cell lung cancer (NSCLC) with ALK-positive mutation
  • Dosage Form Capsule
  • Feature Highly selective, potent ALK inhibitor for NSCLC
  • Ingredients Alectinib Hydrochloride, Excipients
  • Application Oral administration for targeted cancer therapy
  • Physical Color/Texture White to off-white powder-filled capsule
  • Click to View more
X

alectinib capsule Price And Quantity

  • 5.2 USD ($)/Bottle
  • 10 Bottle
  • 5.10 - 6.00 USD ($)/Bottle
  • Prescription only
  • Approximately 37% (oral)
  • Oncology drug
  • Approved in multiple countries including US, EU, and Japan
  • >99%
  • For use under medical supervision only
  • Oral
  • Blister pack or bottle
  • 1256580-46-7
  • L01XE36
  • Hard gelatin capsule containing white to off-white powder
  • 150 mg per capsule

alectinib capsule Product Specifications

  • Alectinib Hydrochloride
  • Highly selective, potent ALK inhibitor for NSCLC
  • Oral administration for targeted cancer therapy
  • Non-small cell lung cancer (NSCLC) with ALK-positive mutation
  • Alectinib Hydrochloride, Excipients
  • White to off-white powder-filled capsule
  • Store below 30C (86F), protect from moisture
  • 24 months
  • Odorless
  • Capsule
  • Prescription only
  • Approximately 37% (oral)
  • Oncology drug
  • Approved in multiple countries including US, EU, and Japan
  • >99%
  • For use under medical supervision only
  • Oral
  • Blister pack or bottle
  • 1256580-46-7
  • L01XE36
  • Hard gelatin capsule containing white to off-white powder
  • 150 mg per capsule

alectinib capsule Trade Information

  • mumbai or DHL or Aramex or EMS
  • Western Union, Paypal, Cash Advance (CA)
  • 50 Bottle Per Day
  • 8 Days
  • Contact us for information regarding our sample policy
  • Western Europe, Australia, North America, Eastern Europe, Middle East, Africa, Central America, South America, Asia
  • All India

Product Description

Alectinib is used to treat a certain type of non-small-cell lung cancer (NSCLC) that has spread to other parts of the body. Alectinib is in a class of medications called kinase inhibitors. It works by blocking the action of an abnormal protein that signals cancer cells to multiply.

Potent Targeted Cancer Therapy

Alectinib is a leading choice for patients with ALK-positive NSCLC. By focusing directly on specific genetic mutations, it delivers improved outcomes and reduced side effects compared to broader chemotherapy agents. This precision allows oncologists to provide effective therapy for those who have tested positive for the ALK mutation.


Convenient Oral Administration

Designed for easy oral consumption, alectinib capsules provide flexibility in treatment scheduling. Patients can take them at home, following medical directions, making the therapy less disruptive to daily life than hospital-based infusions. This convenience is especially beneficial for long-term cancer management.


Stringent Quality and Safety

Alectinib capsules are manufactured and exported with strict adherence to global quality standards. Only available by prescription and under medical supervision, this ensures that dosage, monitoring, and management align with international safety protocols, giving patients peace of mind throughout their therapy.

FAQ's of alectinib capsule:


Q: How should alectinib capsules be taken for NSCLC treatment?

A: Alectinib capsules must be taken orally following the dosing schedule prescribed by an oncologist. It is important to take the capsules whole, usually twice daily, with food, and not to crush or chew them.

Q: What is the indication for prescribing alectinib?

A: Alectinib is specifically indicated for patients with non-small cell lung cancer (NSCLC) that shows ALK-positive genetic mutation, as confirmed by laboratory tests.

Q: When is alectinib recommended during lung cancer management?

A: Alectinib is typically recommended when a patient's NSCLC tests positive for the ALK gene mutation, either during initial therapy or if prior ALK inhibitor treatments are no longer effective.

Q: Where is alectinib approved and available for use?

A: Alectinib is approved for use in numerous countries including the United States, European Union member states, and Japan. It is available through prescription from licensed medical providers.

Q: What are the benefits of using alectinib capsules?

A: The main benefits include highly selective targeting of tumors with ALK mutations, improved survival rates, fewer severe side effects compared to traditional chemotherapy, and oral administration convenience.

Q: What storage conditions are required for alectinib capsules?

A: Store alectinib capsules below 30C (86F), protect them from moisture, and keep them within the original packaging to ensure efficacy and maintain shelf life.

Q: Can alectinib capsules be obtained without a prescription?

A: No, alectinib capsules are an oncology medication only available by prescription and should be used under strict medical supervision to ensure patient safety.

Tell us about your requirement
product

Price:

Quantity
Select Unit

  • 50
  • 100
  • 200
  • 250
  • 500
  • 1000+
Additional detail
Mobile number

Email

Other Products in 'Anti Cancer Drugs' category



Back to top